Radial turbine cooling

Radial turbines have been used extensively in many applications including small ground based electrical power generators, automotive engine turbochargers and aircraft auxiliary power units. In all of these applications the turbine inlet temperature is limited to a value commensurate with the material strength limitations and life requirements of uncooled metal rotors. To take advantage of all the benefits that higher temperatures offer, such as increased turbine specific power output or higher cycle thermal efficiency, requires improved high temperature materials and/or blade cooling. Extensive research is on-going to advance the material properties of high temperature superalloys as well as composite materials including ceramics. The use of ceramics with their high temperature potential and low cost is particularly appealing for radial turbines. However until these programs reach fruition the only way to make significant step increases beyond the present material temperature barriers is to cool the radial blading

Experimental evaluation of a translating nozzle sidewall radial turbine

Studies have shown that reduced specific fuel consumption of rotorcraft engines can be achieved with a variable capacity engine. A key component in such an engine in a high-work, high-temperature variable geometry gas generator turbine. An optimization study indicated that a radial turbine with a translating nozzle sidewall could produce high efficiency over a wide range of engine flows but substantiating data were not available. An experimental program with Teledyne CAE, Toledo, Ohio was undertaken to evaluate the moving sidewall concept. A variety of translating nozzle sidewall turbine configurations were evaluated. The effects of nozzle leakage and coolant flows were also investigated. Testing was done in warm air (121 C). The results of the contractual program were summarized

Aerodynamic Evaluation of Two Compact Radial-Inflow Turbine Rotors

The aerodynamic evaluation of two highly loaded compact radial turbine rotors was conducted at the NASA Lewis Research Center Small Engine Component Test Facility (SECTF). The experimental results were used for proof-of-concept, for modeling radial inflow turbine rotors, and for providing data for code verification. Two rotors were designed to have a shorter axial length, up to a 10-percent reduced diameter, a lighter weight, and equal or higher efficiencies with those of conventional radial inflow turbine rotors. Three configurations were tested: rotor 1, having a 40-percent shorter axial length, with the design stator (stator 1); rotor 1 with the design stator vanes closed down (stator 2); and rotor 2, slightly shorter axially and having higher loading, with stator 2. The stator had 36 vanes and the rotors each had 14 solid blades. Although presently uncooled, the rotor blades were designed for thicknesses which would allow cooling passages to be added. The overall stage performance measurements and the rotor and stator exit flow field surveys were obtained. Measurements of steady state temperatures, pressures, mass flow rates, flow angles, and output power were made at various operating conditions. Data were obtained at corrected speeds of 80, 90, 100, 110, and 120 percent of design over a range of equivalent inlet-to-exit pressure ratios of 3.5, 4.0, 4.5, and 5.0, the maximum pressure ratio achieved. The test showed that the configuration of rotor 1 with stator 1 running at the design pressure ratio produced a flow rate which was 5.6 percent higher than expected. This result indicated the need to close down the stator flow area to reduce the flow. The flow area reduction was accomplished by restaggering the vanes. Rotor 1 was retested with the closed-down stator vanes and achieved the correct mass flow. Rotor 2 was tested only with the restaggered vanes. The test results of the three turbine configurations were nearly identical. Although the measured efficiencies of the compact designs fell 2 to 3 points below the predicted efficiency of 91 percent, they did meet and exceed by up to 2.5 percentage points the efficiences of state-of-the-art turbines found in the literature

Ancient papillomavirus-host co-speciation in Felidae

The evolutionary rate of feline papillomaviruses is inferred from the phylogenetic analysis of their hosts, providing evidence for long-term virus-host co-speciatio

Immunological Change in a Parasite-Impoverished Environment: Divergent Signals from Four Island Taxa

Dramatic declines of native Hawaiian avifauna due to the human-mediated emergence of avian malaria and pox prompted an examination of whether island taxa share a common altered immunological signature, potentially driven by reduced genetic diversity and reduced exposure to parasites. We tested this hypothesis by characterizing parasite prevalence, genetic diversity and three measures of immune response in two recently-introduced species (Neochmia temporalis and Zosterops lateralis) and two island endemics (Acrocephalus aequinoctialis and A. rimitarae) and then comparing the results to those observed in closely-related mainland counterparts. The prevalence of blood parasites was significantly lower in 3 of 4 island taxa, due in part to the absence of certain parasite lineages represented in mainland populations. Indices of genetic diversity were unchanged in the island population of N. temporalis; however, allelic richness was significantly lower in the island population of Z. lateralis while both allelic richness and heterozygosity were significantly reduced in the two island-endemic species examined. Although parasite prevalence and genetic diversity generally conformed to expectations for an island system, we did not find evidence for a pattern of uniformly altered immune responses in island taxa, even amongst endemic taxa with the longest residence times. The island population of Z. lateralis exhibited a significantly reduced inflammatory cell-mediated response while levels of natural antibodies remained unchanged for this and the other recently introduced island taxon. In contrast, the island endemic A. rimitarae exhibited a significantly increased inflammatory response as well as higher levels of natural antibodies and complement. These measures were unchanged or lower in A. aequinoctialis. We suggest that small differences in the pathogenic landscape and the stochastic history of mutation and genetic drift are likely to be important in shaping the unique immunological profiles of small isolated populations. Consequently, predicting the impact of introduced disease on the many other endemic faunas of the remote Pacific will remain a challenge

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

A Canine Distemper Virus Epidemic in Serengeti Lions (Panthera leo)

Canine distemper virus (CDV) is thought to have caused several fatal epidemics in canids within the Serengeti–Mara ecosystem of East Africa, affecting silver-backed jackals (Canis mesomelas) and bat-eared foxes (Otocyon megalotis) in 1978 and African wild dogs (Lycaon pictus) in 1991. The large, closely monitored Serengeti lion population was not affected in these epidemics. However, an epidemic caused by a morbillivirus closely related to CDV emerged abruptly in the lion population of the Serengeti National Park, Tanzania, in early 1994, resulting in fatal neurological disease characterized by grand mal seizures and myoclonus; the lions that died had encephalitis and pneumonia. Here we report the identification of CDV from these lions, and the close phylogenetic relationship between CDV isolates from lions and domestic dogs. By August 1994, 85% of the Serengeti lion population had anti-CDV antibodies, and the epidemic spread north to lions in the Maasai Mara National reserve, Kenya, and uncounted hyaenas, bat-eared foxes, and leopards were also affected

Epizootiology and Management of Feline Leukemia Virus in the Florida Puma

Feline leukemia virus (FeLV) was not detected in Florida pumas (Puma concolor coryi) in almost 20 yr of surveillance; however, the finding of two FeLV antigen-positive pumas during the 2002–2003 capture season led to an investigation of FeLV in the population. Between January 1990 and April 2007, the proportion of pumas testing FeLV antibody positive increased, with antibody-positive pumas concentrated in the northern portion of puma range. Five of 131 (4%) pumas sampled between July 2000 and April 2007 were viremic, with all cases clustered in Okaloacoochee Slough (OKS). Clinical signs and clinical pathology at capture were absent or included lymphadenopathy, moderate-to-severe anemia, and lymphopenia. All viremic pumas died; causes of death were septicemia (n=2), intraspecific aggression (n=2), and anemia/dehydration (n=1). Outcome after FeLV exposure in pumas was similar to that in domestic cats, with evidence of regressive, latent, and persistent infections. Management of the epizootic included vaccination, and as of April 2007, 52 free-ranging pumas had received one or more inoculations. Vaccinations were concentrated in OKS and in a band between OKS and the remainder of the puma population. There have been no new cases since July 2004; however, the potential for reintroduction of the virus remains